{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:45:55Z","timestamp":1789530355831,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,5]]},"DOI":"10.7759\/cureus.38584","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T13:54:27Z","timestamp":1683294867000},"source":"Crossref","is-referenced-by-count":5,"title":["Clinical Disease States Related to Mutations of the NOD2 Gene: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Jasmit","family":"Walia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Mujahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12721","article-title":"Molecular evidence for two forms of Crohn disease","volume":"91","author":"Gilberts EC","year":"1994","unstructured":"Gilberts EC, Greenstein AJ, Katsel P, Harpaz N, Greenstein RJ. Molecular evidence for two forms of Crohn disease. Proc Natl Acad Sci U S A. 1994, 91:12721-4. 10.1073\/pnas.91.26.12721","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006177","article-title":"Nod2: the intestinal gate keeper","volume":"13","author":"Al Nabhani Z","year":"2017","unstructured":"Al Nabhani Z, Dietrich G, Hugot JP, Barreau F. Nod2: the intestinal gate keeper. PLoS Pathog. 2017, 13:e1006177. 10.1371\/journal.ppat.1006177","journal-title":"PLoS Pathog"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot JP","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, et al.. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001, 411:599-603. 10.1038\/35079107","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection","volume":"278","author":"Girardin SE","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, et al.. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003, 278:8869-72. 10.1074\/jbc.C200651200","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.11.002","article-title":"Management of clopidogrel hypersensitivity without drug interruption","volume":"107","author":"Campbell KL","year":"2011","unstructured":"Campbell KL, Cohn JR, Fischman DL, Walinsky P, Mallya R, Jaffrani W, Savage MP. Management of clopidogrel hypersensitivity without drug interruption. Am J Cardiol. 2011, 107:812-6. 10.1016\/j.amjcard.2010.11.002","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2015.03.009","article-title":"PRR-signaling pathways: learning from microbial tactics","volume":"27","author":"Sellge G","year":"2015","unstructured":"Sellge G, Kufer TA. PRR-signaling pathways: learning from microbial tactics. Semin Immunol. 2015, 27:75-84. 10.1016\/j.smim.2015.03.009","journal-title":"Semin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.071795","article-title":"NOD2 regulation of toll-like receptor responses and the pathogenesis of Crohn's disease","volume":"54","author":"Watanabe T","year":"2005","unstructured":"Watanabe T, Kitani A, Strober W. NOD2 regulation of toll-like receptor responses and the pathogenesis of Crohn's disease. Gut. 2005, 54:1515-8. 10.1136\/gut.2005.071795","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50019","article-title":"Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan","volume":"124","author":"Bonen DK","year":"2003","unstructured":"Bonen DK, Ogura Y, Nicolae DL, et al.. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003, 124:140-6. 10.1053\/gast.2003.50019","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.29","article-title":"NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease","volume":"4","author":"Strober W","year":"2011","unstructured":"Strober W, Watanabe T. NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol. 2011, 4:484-95. 10.1038\/mi.2011.29","journal-title":"Mucosal Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2015.1047403","article-title":"Expression and activity of NOD1 and NOD2\/RIPK2 signalling in mononuclear cells from patients with rheumatoid arthritis","volume":"45","author":"Franca R","year":"2016","unstructured":"Franca R, Vieira SM, Talbot J, et al.. Expression and activity of NOD1 and NOD2\/RIPK2 signalling in mononuclear cells from patients with rheumatoid arthritis. Scand J Rheumatol. 2016, 45:8-12. 10.3109\/03009742.2015.1047403","journal-title":"Scand J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev207","article-title":"NOD2-associated autoinflammatory disease: a large cohort study","volume":"54","author":"Yao Q","year":"2015","unstructured":"Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2-associated autoinflammatory disease: a large cohort study. Rheumatology (Oxford). 2015, 54:1904-12. 10.1093\/rheumatology\/kev207","journal-title":"Rheumatology (Oxford)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2019.1613382","article-title":"Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine","volume":"52","author":"Yao Q","year":"2019","unstructured":"Yao Q, Li E, Shen B. Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine. Autoimmunity. 2019, 52:48-56. 10.1080\/08916934.2019.1613382","journal-title":"Autoimmunity"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.675","article-title":"The association of nucleotide-binding oligomerization domain 2 gene polymorphisms with the risk of asthma in the Chinese Han population","volume":"7","author":"Cai X","year":"2019","unstructured":"Cai X, Xu Q, Zhou C, Zhou L, Dai W, Ji G. The association of nucleotide-binding oligomerization domain 2 gene polymorphisms with the risk of asthma in the Chinese Han population. Mol Genet Genomic Med. 2019, 7:e00675. 10.1002\/mgg3.675","journal-title":"Mol Genet Genomic Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi087","article-title":"NOD1 variation, immunoglobulin E and asthma","volume":"14","author":"Hysi P","year":"2005","unstructured":"Hysi P, Kabesch M, Moffatt MF, et al.. NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet. 2005, 14:935-41. 10.1093\/hmg\/ddi087","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes404","article-title":"Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis","volume":"52","author":"Plantinga TS","year":"2013","unstructured":"Plantinga TS, Fransen J, Knevel R, et al.. Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis. Rheumatology (Oxford). 2013, 52:806-14. 10.1093\/rheumatology\/kes404","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S137606","article-title":"NOD2 and inflammation: current insights","volume":"11","author":"Negroni A","year":"2018","unstructured":"Negroni A, Pierdomenico M, Cucchiara S, Stronati L. NOD2 and inflammation: current insights. J Inflamm Res. 2018, 11:49-60. 10.2147\/JIR.S137606","journal-title":"J Inflamm Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2011.06.003","article-title":"Role of NOD1\/CARD4 and NOD2\/CARD15 gene polymorphisms in cancer etiology","volume":"72","author":"Kutikhin AG","year":"2011","unstructured":"Kutikhin AG. Role of NOD1\/CARD4 and NOD2\/CARD15 gene polymorphisms in cancer etiology. Hum Immunol. 2011, 72:955-68. 10.1016\/j.humimm.2011.06.003","journal-title":"Hum Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.09.028","article-title":"A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease","volume":"130","author":"Yao Q","year":"2017","unstructured":"Yao Q, Shen B. A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease. Am J Med. 2017, 130:365.e13-8. 10.1016\/j.amjmed.2016.09.028","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.895765","article-title":"Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis","volume":"13","author":"Matsuda T","year":"2022","unstructured":"Matsuda T, Kambe N, Takimoto-Ito R, et al.. Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis. Front Immunol. 2022, 13:895765. 10.3389\/fimmu.2022.895765","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1977-3","article-title":"NOD2 polymorphism predicts response to treatment in Crohn's disease - first steps to a personalized therapy","volume":"57","author":"Niess JH","year":"2012","unstructured":"Niess JH, Klaus J, Stephani J, et al.. NOD2 polymorphism predicts response to treatment in Crohn's disease - first steps to a personalized therapy. Dig Dis Sci. 2012, 57:879-86. 10.1007\/s10620-011-1977-3","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154537-clinical-disease-states-related-to-mutations-of-the-nod2-gene-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:41Z","timestamp":1707508661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154537-clinical-disease-states-related-to-mutations-of-the-nod2-gene-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.38584","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,5]]}}}